Trial Profile
A Real-Life, Single Center Study To Evaluate the Efficacy and Safety of Sofosbuvir-Based Treatment Regimens in Patients With Chronic Hepatitis C.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Aug 2015
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary) ; Daclatasvir; Interferon; Ribavirin; Simeprevir
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 11 Aug 2015 New trial record